HIV VACCINE TRIALS NETWORK
Hiv Vaccine Trials Network is a health care based firm that specializes in the development & testing of vaccines to prevent HIV/AIDS.
HIV VACCINE TRIALS NETWORK
Industry:
Biotechnology Health Care Medical Device Pharmaceutical
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.hvtn.org
Total Employee:
101+
Status:
Active
Contact:
206-667-6300
Technology used in webpage:
Euro IIS Apple Whitelist IIS 7 Microsoft Office SharePoint Microsoft SharePoint Server 2010
Official Site Inspections
http://www.hvtn.org Semrush global rank: 4.13 M Semrush visits lastest month: 2.91 K
- Host name: css.fhcrc.org
- IP address: 140.107.88.213
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Hiv Vaccine Trials Network"
About HVTN
The HVTN’s mission is to fully characterize the safety, immunogenicity, and efficacy of HIV vaccine candidates with the goal of developing a safe, effective vaccine as rapidly as possible for prevention of HIV globally. ... In the process, …See details»
HIV Vaccine Trials Network (HVTN) | NIAID: National …
The HVTN’s mission is to fully characterize the safety, immunogenicity, and efficacy of HIV vaccine candidates with the goal of developing a safe, effective vaccine as rapidly as possible for prevention of HIV globally. Funding is …See details»
Study Clinics - HVTN
These teams are knowledgeable about their local epidemics and local populations, enabling the HVTN to achieve our mission. Supported through a cooperative agreement with the NIAID of …See details»
HIV Vaccine Trials Network - Wikipedia
The HIV Vaccine Trials Network (HVTN) is a non-profit organization which connects physicians and scientists with activists and community educators for the purpose of conducting clinical trials seeking a safe and effective HIV vaccine. Collaboratively, researchers and laypeople review potential vaccines for safety, immune response, and efficacy. The HVTN is a network for testing vaccines, and while its members may also work in vaccine development for other entities, the m…See details»
HIV Vaccine Trials Network: activities and achievements of the first ...
The HIV Vaccine Trials Network (HVTN) is an international collaboration of scientists and educators facilitating the development of HIV/AIDS preventive vaccines. ... The organization of …See details»
HIV Vaccine Trials Network (HVTN)—Ancillary/Exploratory Studies
Nov 17, 2017 The HVTN shares data and specimens collected in its studies with investigators who would like to use our materials to answer research questions related to vaccinology, …See details»
Research productivity and collaboration of the NIH-funded HIV …
Jan 22, 2021 The global network of all HVTN clinical trial sites through 2019 and the prevalence of HIV among people ages 15–49 in 2017 are shown in Figure 2. The HVTN had clinical trial …See details»
NIH Launches Clinical Trial of Three mRNA HIV Vaccines
Mar 14, 2022 The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched a Phase 1 clinical trial evaluating three …See details»
Scientific Programs Overview - HVTN
The HVTN conducts all phases of clinical trials, bringing together experts from many backgrounds. Through this collaborative effort, the HVTN helps advance the HIV vaccinology …See details»
HIV Vaccine Trials Network: activities and achievements of the first ...
The HIV Vaccine Trials Network (HVTN) is an international collaboration of scientists and educators facilitating the development of HIV/AIDS preventive vaccines. The HVTN conducts …See details»
The importance of partnerships in accelerating HIV vaccine …
Nov 21, 2021 Clinical trial networks, such as the HIV Vaccine Trials Network (HVTN) and the HIV Prevention Trials Network, along with other clinical development activities funded by …See details»
HVTN - Fred Hutch
This program supports the HVTN Site Affiliated Laboratories to maintain HVTN-quality standards, training, certification, and monitoring for specimen handling and processing. By providing high …See details»
After 20 years, Wakefield retires from HIV Vaccine Trials Network
Jul 7, 2020 “He has been, for me, a moral compass, a wise adviser and a close friend,” said former Fred Hutch president and director Dr. Larry Corey, who cofounded the HVTN. When …See details»
First new HIV vaccine efficacy study in seven years has begun
Nov 28, 2016 HVTN 100 and HVTN 702 are part of a larger HIV vaccine research endeavor led by the Pox-Protein Public-Private Partnership, or P5 — a diverse group of public and private …See details»
Events - HVTN
2025 HVTN Full Group Meeting May 7-9, 2025. Omni Shoreham Hotel Washington, D.C.See details»
Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine
Nov 28, 2013 This study, called HVTN 505, was a randomized, double-blind, placebo-controlled trial of the VRC's DNA/rAd5 HIV-1 vaccine. To be eligible for the study, men and transgender …See details»
News - HVTN
News on HVTN Read MORE A promising HIV vaccine candidate gets a little help New strategy stirs a robust response from T cells tracked by McElrath lab May 24, 2023See details»
Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C …
Mar 24, 2021 (HVTN 702 ClinicalTrials.gov number, NCT02968849.) Quick Take. Vaccine Efficacy of ALVAC-HIV (vCP2438) and Bivalent Subtype C gp120–MF59 in HIV-Uninfected …See details»
Experimental HIV Vaccine Regimen Safe but Ineffective, NIH Study …
Jan 18, 2023 An investigational HIV vaccine regimen tested among men who have sex with men (MSM) and transgender people was safe but did not provide protection against HIV …See details»